3-Chlorobenzenesulphonyl chloride → HCID 58728405, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([S:8](Cl)(=[O:10])=[O:9])[CH:5]=[CH:6][CH:7]=1.[CH3:12][C:13]1[N:17]([CH:18]2[CH2:24][C@H:23]3[N:25]([CH2:26][CH2:27][C:28]4([C:34]5[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=5)[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]4)[C@H:20]([CH2:21][CH2:22]3)[CH2:19]2)[C:16]2[CH:40]=[CH:41][CH:42]=[CH:43][C:15]=2[N:14]=1>C(Cl)Cl.CCOC(C)=O>[Cl:1][C:2]1[CH:3]=[C:4]([S:8]([N:31]2[CH2:30][CH2:29][C:28]([CH2:27][CH2:26][N:25]3[C@H:20]4[CH2:21][CH2:22][C@@H:23]3[CH2:24][CH:18]([N:17]3[C:16]5[CH:40]=[CH:41][CH:42]=[CH:43][C:15]=5[N:14]=[C:13]3[CH3:12])[CH2:19]4)([C:34]3[CH:35]=[CH:36][CH:37]=[CH:38][CH:39]=3)[CH2:33][CH2:32]2)(=[O:10])=[O:9])[CH:5]=[CH:6][CH:7]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
3-Chlorobenzenesulfonyl chloride (31.6 mg, 0.122 mmol) was added to a solution of 2-methyl-1-{(1R,5S)-8-[2-(4-phenyl-4-piperidinyl)ethyl]-8-azabicyclo[3.2.1]oct-3-yl}-1H-benzimidazole (50.0 mg, 0.117 mmol) and diisopropyletheylamine (44.9 mg, 0.348 mmol) in DCM. The reactions were quenched with sat. NaHCO3 and separated with a hydrophobic frit. Flash chromatography on silica 0 to 10% MeOH in EtOAc afforded 1-[(1R,5S)-8-(2-{1-[(3-chlorophenyl)sulfonyl]-4-phenyl-4-piperidinyl}ethyl)-8-azabicyclo[3.2.1]oct-3-yl]-2-methyl-1H-benzimidazole 14.7 mg (20% yield). MS ES+ 603 (M+H). 1H NMR (300 MHz, chloroform-d) δ ppm 1.6 (m, 2H), 1.7 (m, 4H), 1.9 (m, 8H), 2.4 (m, 4H), 2.6 (s, 3H), 2.8 (m, 2H), 3.4 (m, 2H), 4.6 (m, 1H), 7.2 (m, 5H), 7.3 (m, 3H), 7.4 (t, J=7.9 Hz, 1H), 7.5 (m, 1H), 7.6 (d, J=7.8 Hz, 1H), 7.7 (m, 1H), 7.7 (m, J=1.8, 1.8 Hz, 1H).
Workup
- customThe reactions were quenched with sat. NaHCO3
- customseparated with a hydrophobic frit
Sources & evidence
- ORD record
- ord-3a8d646fe5f8478e89c429a9c160e15d
- Source dataset
- uspto-grants-2010_01
- Patent number
- US07645771B2
Reaction notes
Loading…